Scrip Asks…What Does 2021 Hold For Biopharma? Part 1: Tackling COVID-19

Biopharma Provides Light At End Of Tunnel

Industry leaders share their expectations around COVID-19 for the coming year. Further product development and vaccine rollout will be key themes in 2021. Equitable supply and addressing the mental health challenges associated with lockdowns also loom large.

Scrip Asks, Part 1
• Source: Shutterstock

More from COVID-19

More from Scrip